سعر جليبافلوز 5 مجم 30 قرص 2026

Ertugliflozin 5 mg film-coated tablets, 30s, listed in Egyptian SGLT2 price directories as Glibafloz (local brand). Manufacturer not verified on the category page used.

• Treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise, as monotherapy when metformin is inappropriate, or in addition to other antidiabetic medicinal products (ertugliflozin, SGLT2 inhibitor).Population: Adults with type 2 diabeteselectronic medicines compendium (emc), UK

• Very common/common: genital mycotic infections, UTI, increased urination, thirst, volume depletion–related events; rare: DKA; not known: Fournier gangrene (class).International label, same formulation · electronic medicines compendium (emc), UK

• Hypersensitivity to ertugliflozin or excipients. Do not use in type 1 diabetes. Discontinue if eGFR falls persistently below the labeled cut-off; not for ESRD/dialysis where ineffective.International label, same formulation · electronic medicines compendium (emc), UK

• Diabetic ketoacidosis (including euglycaemic DKA) — interrupt for major surgery/acute illness; assess ketones if suggestive symptoms occur regardless of glucose.International label, same formulation · electronic medicines compendium (emc), UK
• Volume depletion/hypotension, genital mycotic infections, UTI, Fournier gangrene risk, lower-limb amputation counselling, and reduced glycaemic efficacy in moderate–severe renal impairment.International label, same formulation · electronic medicines compendium (emc), UK

• DiureticsModerateMay add to diuretic effect and increase dehydration/hypotension risk.electronic medicines compendium (emc), UK
• Insulin / sulfonylureasModerateMay increase hypoglycaemia risk — consider lower secretagogue/insulin dose.electronic medicines compendium (emc), UK

• ertugliflozin should not be used during pregnancy (animal data suggest possible effects on renal development/maturation).International label, same formulation · electronic medicines compendium (emc), UK
• Do not use ertugliflozin during breastfeeding; excreted in animal milk and a risk to the newborn/infant cannot be excluded.International label, same formulation · electronic medicines compendium (emc), UK

• Ertugliflozin: Inhibits SGLT2 in proximal tubules, reducing glucose reabsorption and increasing urinary glucose excretion.